Search

everythinglearnresearchcommunity

for

Search:↓

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

Older adults still engage in sexual activities but face challenges like health issues and lack of professional support, highlighting the need for better healthcare provider education and research on sexual fulfillment in old age.

A new method was developed to accurately measure enzyme activity related to prostate health.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

Glioblastoma cells can make androgens, which might help the tumor grow.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Hsc70 protein may influence hair growth by responding to androgens.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.